Single LSD dose provides lasting relief from anxiety, researchers find
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
Stay updated with breaking news from Benefit Corp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
MM120, an LSD formulation designed to treat generalized anxiety disorder, was recently granted a breakthrough therapy designation by the FDA.
The VA is seeking “definitive scientific evidence on the potential efficacy and safety of psychedelic compounds” such as MDMA and psilocybin to treat PTSD.